Fertility & Menopause: OOVA's solution

The Hormone Blind Spot: How Oova Is Turning Women's Health Data Into Power 1 in 6 people will experience infertility. By 2030, more than a billion women will be going through perimenopause or menopause. Many will spend years with symptoms while being told their labs look "normal." In this episode, Kristina Karcic and Jen Bolcar sit down with Dr. Amy Divaraniya, Founder & CEO of Oova, and Ioana Calcev, COO, to talk about why hormone health is still one of healthcare's biggest blind spots, and how Oova is changing that. We talk about: • Amy's journey from precision medicine and genomics to building the solution she wished had existed • How Oova's at-home urine test measures LH, estrogen and progesterone, with 99% correlation to blood testing • Why real hormone numbers, tracked over time, give women and their doctors answers that a single lab result can't • The business case for employers and what's still missing from today's fertility and menopause benefits • What it takes to grow a startup product into a healthcare platform used by hundreds of clinics and hospitals Learn more about Oova: https://oova.life Startup RealTalk is brought to you by Karcic Partners.